HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Lopez-Sendon Selected Research

orbofiban

7/2000Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Lopez-Sendon Research Topics

Disease

4Myocardial Infarction
11/2011 - 07/2000
2Ischemia
11/2011 - 07/2000
2Acute Coronary Syndrome
11/2011 - 07/2000
1Myocardial Ischemia (Ischemic Heart Diseases)
11/2011
1Ventricular Tachycardia
11/2011
1Heart Failure
01/2001
1Cardiogenic Shock
12/2000
1Hemorrhage
07/2000
1Intracranial Hemorrhages (Intracranial Hemorrhage)
07/2000
1Stroke (Strokes)
07/2000

Drug/Important Bio-Agent (IBA)

1Neurofibromin 2 (Merlin)IBA
11/2011
1RanolazineFDA Link
11/2011
1Eplerenone (Inspra)FDA LinkGeneric
01/2001
1Abciximab (ReoPro)FDA Link
12/2000
1Glycoproteins (Glycoprotein)IBA
07/2000
1orbofibanIBA
07/2000

Therapy/Procedure

1Stents
12/2000
1Therapeutics
12/2000
1Percutaneous Coronary Intervention
07/2000
1Patient Readmission
07/2000